Stilo going GREAT GUNS13 Aug 2019 10:48
Although the share price is at the bottom of its 10 year trading range and whilst the BOD issued a rather cautionary AGM statement ,it is safe to say that Migrate and AuthorBridge are making inroads into the market place.
The Rapid Prototyping Program combines validated content management technology from Astoria Software, process automation technology from TransPerfect, critical conversion technology from Stilo and information development services from leading consultant Mekon."
With "TransPerfect’s Rapid Prototyping Program now enabling device makers to build an evidence-based business case for management approval."(July 18th 2019)
"Industry-wide, the cost of implementing the EU’s new MDR and IVDR requirements is estimated at nearly $20 billion. A significant portion of that cost is due to new content requirements. Says TransPerfect MDS President Marc Miller, “Two critical areas affected by MDR and IVDR are labeling – including translations – and post-market surveillance. The new regulations will create a substantial, permanent increase in the volume and velocity of content in both of these areas. The only practical way to address this increase is through automation and AI.”
The Transperfect collaboration swiftly followed on from Componize Software and Stilo International announcing their partnership and product integration where "AuthorBridge offers an optimal authoring experience for SMEs, and integrates perfectly with Componize’s CCMS".
ALSO,Stilo has recently announced(without any fanfare)maiden contracts with both Intel and Visa !
It is exceedingly reassuring that Mike Iantosca, leader of IBM's central ID Tools team, continues in 2019 to oversee the implementation and integration of AuthorBridge thus enabling their CCMS users with the ability to virtually walk-up and use with minimal training, as well as providing the wider business benefits for intelligent content authoring.
It is also worth noting that, irrespective of the current waves of negativity,Chairman David Ashman stated in the Prelims, released in March,that we, "look forward to growing future sales, supported by healthy cash reserves and a strong balance sheet".
INTERESTING